Global News and Digital Insights
for the Healthcare Industry

Ipsen scales in Ireland with $50M investment in its facilities

As Ireland proceeds ahead to become the hub of pharma manufacturing projects, Ipsen becomes the latest company to hop on the bandwagon. Ipsen revealed the €52 million ($49.9 million) extension of its active pharmaceutical ingredient manufacturing facility on Monday. The investment aims to increase the manufacturing of ingredients and medications for cancer and other uncommon diseases. An executive at Ipsen has announced that the site is currently employing 175 workers, with a 20% increase in its existing workforce, especially in its research and development sector.

Read More from EndPts

Facebook
Twitter
LinkedIn